Xtl Biopharma ADR (XTLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2017 | 09-2017 | 06-2017 | 03-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | 0 | 0 | N/A | -2,545 |
| Depreciation Amortization | N/A | 0 | 0 | N/A | 851 |
| Accounts payable and accrued liabilities | N/A | 0 | 0 | N/A | -101 |
| Other Working Capital | N/A | 0 | 0 | N/A | -220 |
| Other Operating Activity | 0 | 0 | 0 | 0 | 283 |
| Operating Cash Flow | $N/A | $0 | $0 | $N/A | $-1,732 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | 0 | 0 | N/A | -2 |
| Purchase Sale Intangibles | N/A | 0 | 0 | N/A | -64 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -64 |
| Investing Cash Flow | $N/A | $0 | $0 | $N/A | $-66 |
| Cash Flows From Financing Activities | |||||
| Financing Cash Flow | $N/A | $0 | $0 | $N/A | $N/A |
| Beginning Cash Position | N/A | 0 | 0 | N/A | 3,817 |
| End Cash Position | N/A | 0 | 0 | N/A | 2,019 |
| Net Cash Flow | $N/A | $0 | $0 | $N/A | $-1,798 |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | 0 | 0 | N/A | -1,732 |
| Capital Expenditure | N/A | 0 | 0 | N/A | -2 |
| Free Cash Flow | 0 | 0 | 0 | 0 | -1,734 |